SUTENT 12.5 MG 28 TB

Sutent (sunitinib) is a medication used primarily in the treatment of various types of cancer, including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET). The formulation you’re referring to, Sutent 12.5 mg tablets, contains sunitinib as the active ingredient. Each tablet typically contains 12.5 mg of sunitinib along with other inactive ingredients. Sunitinib belongs to a class of drugs known as tyrosine kinase inhibitors. It works by blocking the action of specific proteins (tyrosine kinases) that are involved in the growth and spread of cancer cells. By inhibiting these proteins, sunitinib helps to slow down or stop the growth of cancer cells, thereby aiding in the treatment of the disease. It’s important to take Sutent exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer, your overall health, and other medications you may be taking. Always follow your doctor’s instructions carefully and report any side effects or concerns promptly.